Insiders Crinetics Pharmaceuticals, Inc.

Equities

CRNX

US22663K1079

Real-time Estimate Cboe BZX Other stock markets 14:20:10 2024-05-14 EDT			5-day change	1st Jan Change
49.42 ^USD	+3.11%		+3.24%	+38.29%

05-10	Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing	MT
05-09	Crinetics Pharmaceuticals Q1 Net Loss Widens	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing	05-10	MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $639,256, According to a Recent SEC Filing	04-17	MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing	03-26	MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $664,763, According to a Recent SEC Filing	03-22	MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $2,648,150, According to a Recent SEC Filing	03-22	MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $449,793, According to a Recent SEC Filing	03-21	MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $354,700, According to a Recent SEC Filing	01-04	MT
Crinetics Pharmaceuticals CEO Sold Shares Worth $6,111,440, According to a Recent SEC Filing	11-07	MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $210,000, According to a Recent SEC Filing	23-10-19	MT
Insider Sell: Crinetics Pharmaceuticals	23-07-13	MT
Insider Sell: Crinetics Pharmaceuticals	23-06-21	MT
Insider Sell: Crinetics Pharmaceuticals	23-06-21	MT
Insider Buy: Crinetics Pharmaceuticals	23-06-09	MT
Insider Sell: Crinetics Pharmaceuticals	23-01-27	MT
Crinetics Pharmaceuticals Appoints Dana Pizzuti as Chief Development Officer	22-10-03	CI
Insider Sell: Crinetics Pharmaceuticals	22-07-15	MT
Insider Sell: Crinetics Pharmaceuticals	22-04-21	MT
Insider Sell: Crinetics Pharmaceuticals	22-04-18	MT
Crinetics Pharmaceuticals, Inc. Announces Resignation of Ajay Madan as Chief Development Officer, Effective April 1, 2022	22-03-25	CI
Crinetics Pharmaceuticals, Inc. Appoints Chris Robillard as Chief Business Officer	22-03-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Crinetics Pharmaceuticals, Inc.

Equities

CRNX

US22663K1079

Insiders

Filters